Results 191 to 200 of about 1,360,599 (360)

The Diagnostic Value of Confocal Laser Endomicroscopy in Brain Tumours When Performed by Blinded, Untrained Neuropathologists. [PDF]

Neuropathol Appl Neurobiol
Iff I, Gutt-Will M, Maragkou T, Mathis A, Seidel K, Capper D, Hain EG, Meinhardt J, Von Manitius R, Dittmayer C, Schmid S, Hewer E, Raabe A, Schucht P.   +13 more
europepmc   +1 more source

Are renal tumour scoring systems better than clinical judgement at predicting partial nephrectomy complexity?

, 2017
Ravi Kumar, Luke T. Lavallée, Darren Desantis, Sonya Cnossen, Ranjeeta Mallick, Ilias Cagiannos, Christopher Morash, Rodney H. Breau   +7 more
openalex   +2 more sources

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

Molecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia, Noelia Moares, Wenjie Yi‐He, Rosa Luna‐Espejo, Ricardo Fernandez‐Cisnal, Javier Ocaña‐Cuesta, Juan P. Muñoz‐Miranda, Antonio Gabucio, Cecilia M. Fernandez‐Ponce, Francisco Garcia‐Cozar   +9 more
wiley   +1 more source

Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas. [PDF]

Endocr Connect
Følling I, Selle ML, Nilsen HR, Wennerström AB, Nilsen HL, Eide TJ.   +5 more
europepmc   +1 more source

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721 [PDF]

, 1981
P R Twentyman
openalex   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Lactic Acid in Tumour Biology. [PDF]

Metabolites
Cruz C, Barba I.
europepmc   +1 more source

In vitro cloning of human breast tumour stem cells: influence of histological grade on the success of cultures [PDF]

, 1982
C Touzet, F Rusé, J Chassagne, Jean-Pierre Ferrière, P. Chollet, R Plagne, Y Fonck, M de Latour   +7 more
openalex   +1 more source

OC03.05: One step forward: undertake the challenge of increasing the diagnostic accuracy of the IOTA ADNEX model in solid tumours [PDF]

, 2020
Adriana Acosta, M. Medina Castellano, Eduardo Quevedo, Gustavo M. Callicó, Ángelo Santana, J. García Hernández, Alicia Martín Martínez   +6 more
openalex   +1 more source

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway

Molecular Oncology, EarlyView.
Cytoplasmic p21 promotes colorectal cancer stem cell (CSC) features by destabilizing the NFκB–IκB complex, activating NFκB signaling, and upregulating BCL‐xL and COX2. In contrast to nuclear p21, cytoplasmic p21 enhances spheroid formation and stemness transcription factor CD133.
Arnatchai Maiuthed, Kerstin Huebner, Katharina Erlenbach‐Wuensch, Chuanpit Hampel, Daniela Thalheim, Adriana Vial‐Roehe, Bodee Nutho, Susanne Merkel, Arndt Hartmann, Pithi Chanvorachote, Regine Schneider‐Stock   +10 more
wiley   +1 more source